Mutenherwa Farirai, Wassenaar Douglas R, de Oliveira Tulio
School of Applied Human Sciences, University of KwaZulu-Natal, Private Bag X01, Scottsville, Pietermaritzburg, 3209, South Africa.
KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa.
BMC Med Ethics. 2019 Oct 7;20(1):67. doi: 10.1186/s12910-019-0403-9.
HIV molecular epidemiology is increasingly recognized as a vital source of information for understanding HIV transmission dynamics. Despite extensive use of these data-intensive techniques in both research and public health settings, the ethical issues associated with this science have received minimal attention. As the discipline evolves, there is reasonable concern that existing ethical and legal frameworks and standards might lag behind the rapid methodological developments in this field. This is a follow-up on our earlier work that applied a predetermined analytical framework to examine the perspectives of a sample of scientists from the fields of epidemiology, public health, virology and bioethics on key ethical issues associated with HIV molecular epidemiology in HIV network research.
Fourteen in-depth interviews were conducted with scientists from the fields of molecular epidemiology, public health, virology and bioethics. Inductive analytical approaches were applied to identify key themes that emerged from the data.
Our interviewees acknowledged the potential positive impact of molecular epidemiology in the fight against HIV. However, they were concerned that HIV phylogenetics research messages may be incorrectly interpreted if not presented at the appropriate level. There was consensus that HIV phylogenetics research presents a potential risk to privacy, but the probability and magnitude of this risk was less obvious. Although participants acknowledged the social value that could be realized from the analysis of HIV genetic sequences, there was a perceived fear that the boundaries for use of HIV sequence data were not clearly defined.
Our findings highlight distinct ethical issues arising from HIV molecular epidemiology. As the discipline evolves and HIV sequence data become increasingly available, it is critical to ensure that ethical standards keep pace with biomedical advancements. We argue that the ethical issues raised in this study, whether real or perceived, require further conceptual and empirical examination.
艾滋病病毒分子流行病学日益被视为理解艾滋病病毒传播动态的重要信息来源。尽管这些数据密集型技术在研究和公共卫生领域得到了广泛应用,但与这门科学相关的伦理问题却很少受到关注。随着该学科的发展,人们有理由担心现有的伦理和法律框架及标准可能会落后于该领域快速的方法学发展。这是我们早期工作的后续研究,早期工作应用了一个预先确定的分析框架,以考察来自流行病学、公共卫生、病毒学和生物伦理学领域的一组科学家对艾滋病病毒网络研究中与艾滋病病毒分子流行病学相关的关键伦理问题的看法。
对分子流行病学、公共卫生、病毒学和生物伦理学领域的科学家进行了14次深入访谈。采用归纳分析方法来确定数据中出现的关键主题。
我们的受访者承认分子流行病学在抗击艾滋病病毒方面可能产生的积极影响。然而,他们担心,如果艾滋病病毒系统发育学研究信息没有在适当层面呈现,可能会被错误解读。大家一致认为,艾滋病病毒系统发育学研究对隐私构成潜在风险,但这种风险的可能性和程度不太明显。尽管参与者承认分析艾滋病病毒基因序列可以实现社会价值,但人们感觉担心的是,艾滋病病毒序列数据的使用界限没有明确界定。
我们的研究结果凸显了艾滋病病毒分子流行病学中出现的独特伦理问题。随着该学科的发展以及艾滋病病毒序列数据越来越容易获取,确保伦理标准跟上生物医学进步至关重要。我们认为,本研究中提出的伦理问题,无论真实存在还是感觉存在,都需要进一步的概念和实证研究。